Biotechnology company Human Genome Sciences Inc. was expected to say on Tuesday that its experimental anthrax drug appears safe for human use based on a recent test, according to The Washington Post. The Rockville, Maryland-based company said on Monday that separate tests in rabbits suggested its drug known as Abthrax might be effective if given within 12 hours of exposure to anthrax, the newspaper reported.
